Baader Bank Aktiengesellschaft
BankPosition in LLY — ELI LILLY & Co
CIK 1542629
Unterschleissheim, 2M
Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$10,703,714
+$8,368,418 QoQ
Shares Held
8,924
+251.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#1,229
of 4,605 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Sep 30, 2022CallValue
$0
CallShares
0
PutValue
$2,263,450
PutShares
7,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baader Bank Aktiengesellschaft holds $38,581,797 across 9 Drug Manufacturers - General names. LLY ranks #1 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
8,924 | $10,703,714 | |
| 2 | JNJ |
Johnson & Johnson
|
38,394 | $9,750,924 | |
| 3 | BIIB |
Biogen Inc.
|
28,568 | $6,172,402 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,582 | $5,214,787 | |
| 5 | ABBV |
AbbVie Inc.
|
10,017 | $2,520,677 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
11,970 | $1,512,289 | |
| 7 | PFE |
Pfizer Inc
|
55,904 | $1,346,168 | |
| 8 | AZN |
Astrazeneca PLC
|
4,699 | $891,024 |
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,703,714 | 8,924 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,335,296 | 2,539 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,168,684 | 3,879 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,286,241 | 4,307 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,995,733 | 3,843 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $4,369,889 | 5,291 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,311,880 | 4,290 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,040,772 | 4,561 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $7,232,175 | 7,988 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $3,167,075 | 4,071 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $606,236 | 1,040 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $943,200 | 1,756 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $365,335 | 779 | Shares | Sole | 2023-08-11 | |
| 2022-12-31 | $621,928 | 1,700 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,435,674 | 4,440 | Shares | Sole | 2023-05-04 | |
| 2022-09-30 | $2,263,450 | 7,000 | Put | Sole | 2023-05-04 | |
| 2022-06-30 | $1,000,573 | 3,086 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||